000 | 01134 a2200325 4500 | ||
---|---|---|---|
005 | 20250517140400.0 | ||
264 | 0 | _c20181015 | |
008 | 201810s 0 0 eng d | ||
022 | _a2078-2101 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAnsari, Mehdi | |
245 | 0 | 0 |
_aPopulation Pharmacokinetics of Imatinib and its application to the therapeutic drug monitoring: Middle East CML population. _h[electronic resource] |
260 |
_bThe Gulf journal of oncology _cSep 2016 |
||
300 |
_a26-36 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
650 | 0 | 4 |
_aDrug Monitoring _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImatinib Mesylate _xpharmacokinetics |
650 | 0 | 4 | _aIran |
650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
650 | 0 | 4 | _aMiddle East |
650 | 0 | 4 | _aPopulation Surveillance |
700 | 1 | _aKalantary-Khandani, Behjat | |
700 | 1 | _aPardakhty, Abbas | |
700 | 1 | _aSafavi, Moein | |
700 | 1 | _aMosavi, Nabi | |
700 | 1 | _aMohajeri, Ehsan | |
773 | 0 |
_tThe Gulf journal of oncology _gvol. 1 _gno. 22 _gp. 26-36 |
|
999 |
_c26874766 _d26874766 |